STOCK ALARM
SA
Menu
⌘K
Set Alert
Demo
Log In
Today
My Portfolio
Find Stocks
The Market
Charts
Research
Advisor
⌘J
ARWR
(ARWR)
ARWR
Overview
Intelligence
Chart
Fundamentals
Key Metrics
Earnings
Growth
Analysts
Financials
Insiders
Institutional
More
Show Technical Panel
Show S&P 500 Navigator
Loading chart...
Key Metrics
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$4.61B
+98.8%
P/E Ratio
-2,828.52
-72982.7%
P/S Ratio
5.56
-99.1%
ROE
-0.35%
+99.9%
ROIC
4.65%
+108.1%
FCF Yield
3.40%
+113.1%
Debt/Equity
0.79
-82.9%
Current Ratio
4.86
-27.9%
Interest Coverage
1.10x
+105.9%
Per Share
Revenue/Share
$6.20
+20817.9%
Net Income/Share
$-0.01
+99.8%
Operating CF/Share
$1.34
+134.7%
Free CF/Share
$1.17
+123.2%
Cash/Share
$6.87
+20.9%
Book Value/Share
$3.76
+136.0%
Tangible Book/Share
$3.71
+143.7%
Equity/Share
$3.48
+125.1%
Interest Debt/Share
$3.41
-53.9%
Valuation
Market Cap
$4.61B
+98.8%
Enterprise Value
$4.75B
+54.9%
P/E Ratio
-2,828.52
-72982.7%
P/S Ratio
5.56
-99.1%
P/OCF Ratio
25.69
+612.5%
P/FCF Ratio
29.41
+865.9%
P/B Ratio
9.90
-20.9%
P/TB Ratio
9.90
-20.9%
EV/Sales
5.73
-99.3%
EV/EBITDA
28.84
+627.5%
Profitability
Earnings Yield
-0.04%
+99.9%
FCF Yield
3.40%
+113.1%
ROE
-0.35%
+99.9%
ROIC
4.65%
+108.1%
Return on Tangible Assets
-0.12%
+99.8%
Capital Allocation
CapEx/OCF
12.62%
+141.3%
CapEx/Revenue
2.73%
-99.9%
CapEx/Depreciation
0.95
-87.5%
SBC/Revenue
7.64%
-99.6%
Balance Sheet
Debt/Equity
0.79
-82.9%
Debt/Assets
0.26
-64.6%
Net Debt/EBITDA
0.85
+163.5%
Current Ratio
4.86
-27.9%
Interest Coverage
1.10x
+105.9%
Income Quality
5.96
+685.4%
Efficiency
Days Sales Outstanding
3 days
Days Payables Outstanding
270 days
+20.6%
Days Inventory
0 days
Receivables Turnover
121.55x
Payables Turnover
1.35x
-17.1%
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$0.32
+114.2%
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
Arrowhead Pharmaceuticals Inc.
(ARWR)
$74.93
▼
-1.46 (-1.91%)
Chart
Share
Post on X
ARWR
Arrowhead Pharmaceuticals Inc.
(ARWR)
NASDAQ
$74.93
▼
-1.46 (-1.91%)
Chart Studio
Share
ARWR